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Background: Current guidelines recommend that transthoracic echocardiography (TTE) should be performed for
acute risk stratification following acute pulmonary embolism (PE), but it is unclear whether the initial TTE can
predict long-term outcome beyond six months. We sought to assess the potential of the initial right atrial (RA) to
left atrial (LA) area ratio (RA/LA ratio) on TTE to predict long-term mortality in survivors of submassive PE.
Methods: A derivation cohort comprised a previously reported group of 35 consecutive patients with acute PE
who were intensively studied by serial TTE at 1, 2, 5 days, 2, 6, 12 and 26 weeks and RA/LA ratio related to
long-term outcome. The Day 1 RA/LA ratio findings were then further related to long-term outcome in 158
patients followed for 3.6 ± 2.3 years.
Results: In the derivation cohort, total mortality was 28.6% (n = 10) following a mean (±standard deviation)
follow-up of 4.3 ± 1.9 years. The RA/LA ratio was highly dynamic, being increased at day 1, but normalised rapidly
within 2–5 days of presentation and this was most marked amongst long-term non-survivors. A RA/LA ratio > 1.0
on day 1 was independently associated with a three-fold increase in long-term mortality on Kaplan-Meier analysis.
Pooled analysis of 158 patient indicated that age, Charlson Comorbidity Index (CCI), simplified Pulmonary Embolism
Severity Score (PESI), troponin T, day 1 RA/LA Ratio and pulmonary arterial systolic pressure (PASP) were univariate
predictors of long-term mortality. Multivariate analysis identified Day 1 RA/LA Ratio (HR 1.7 per 10% increase,
p = 0.002), CCI (HR 2.2 per 1 unit increase, p = 0.004) and age (HR 1.1, p = 0.03) as the only independent predictors
of long-term mortality.
Conclusion: A RA/LA Ratio >1.0 at presentation with acute PE was associated with a three-fold increased risk of
long-term mortality. The RA/LA ratio on presentation with an acute PE is a simple, novel predictor of long-term
survival.Introduction
Acute pulmonary embolism (PE) is common and associ-
ated with an early case fatality rate of 7-11% [1], and a
reported 5-year cumulative mortality rate of up to 32%
[2]. Clinical scores have been developed and validated in
predicting short-term prognosis following acute PE
[3-5]. Current guidelines recommend transthoracic
echocardiography (TTE) should be performed for early
risk stratification following acute PE [6]. After massive
PE, right ventricular (RV) dysfunction on TTE, an* Correspondence: leonard.kritharides@sydney.edu.au
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reproduction in any medium, provided the orenlarged right atrium (RA) with reduced left atrial (LA)
size on computed tomography are prominent features
and indicate worse acute prognosis [6-8].
Some predictors of adverse long-term outcomes after
PE have been identified. These include initial troponin
elevation, baseline comorbidities as assessed by the
Charlson Comorbidity Index (CCI) and ongoing func-
tional impairment post PE [9-14]. However, relatively lit-
tle is still known about the long-term outcome of
patients with PE. In particular, the ability of cardiac im-
aging parameters obtained early during acute PE to de-
termine long-term prognosis in patients with submassive
PE who survive to hospital discharge is particularly un-
clear [8]. In other conditions involving right heart straintd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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RA dilation both confer significantly worse long-term
prognosis [15,16]. While quantification of RV dysfunc-
tion is still evolving, RA size, either assessed as planim-
etry area or as RA/LA area ratio, is robust and easily
measured on TTE or on CTPA and has been shown to
correlate with the severity of the pulmonary arterial ob-
struction in submassive PE [17,18]. The greater the clot
burden in the pulmonary arteries, the smaller the LA
area and the larger the RA area become, thus resulting
in an increased RA/LA area ratio. When patients present
with an acute PE to the emergency department, the RA/
LA area ratio, which can be easily measured, obtained
instantaneously and is highly reproducible on echocardi-
ography without the need for further post-processing as
required by more complex strain assessment of right
heart function, may be useful to the clinician. To the
best of our knowledge, no study to date has examined
the utility of the RA/LA area ratio, assessed early by
TTE, in prognosticating the long-term mortality risk of
patients post submassive PE.
The present study examined both the natural history
changes to the RA/LA area ratio in patients with acute
submassive PE, and additionally investigated the long-
term prognostic significance of the RA/LA area ratio in
these patients. Furthermore, we sought to determine
whether a specific RA/LA area ratio cutoff on echocardi-
ography is an independent prognostic marker for long-
term outcomes in patients with submassive PE.
Methods
Derivation cohort
The design of the derivation cohort study has been de-
scribed previously [19]. Thirty-five patients (mean age
[±standard deviation] 63 ± 18years) with a clinical diag-
nosis of PE confirmed by a high probability ventilation/
perfusion (V/Q) pulmonary scintigraphy for PE were
prospectively recruited from 2004 in a tertiary institu-
tion. Submassive PE was defined as involvement of 30%
or greater lung parenchyma and massive PE was defined
as involvement of 50% or greater lung parenchyma. Bio-
chemical profiling (cardiac troponin-T, brain natriuretic
peptide [BNP], D-dimer, C-reactive protein [CRP]) and
serial TTE assessing RV function were performed on
days 1, 2, 5 and weeks 2, 6, 12 and 26 following admis-
sion. All patients received systemic anticoagulation for a
minimum of 6 months. The overall comorbid burden
and short-term mortality risk of each patient was
assessed and given a Charlson Comorbidity Index (CCI)
score [20] and a simplified Pulmonary Embolus Severity
Index (PESI) score respectively [3]. For all survivors,
final follow-up visit for a full clinical and physical exam-
ination was completed in December 2010 (mean follow-
up 4.3 ± 1.9years).Validation cohort
A larger validation cohort was derived from a previously
published series of consecutive patients from 2001–2007
with outcome status and follow-up completed in July
2008 (mean follow-up 3.8 ± 2.6 years) [2]. From this
group of 1023 patients, 123 were identified who under-
went TTE on day 1 of admission and were further stud-
ied. These patients were used as the validation cohort.
The age, gender, simplified PESI score, CCI score and
clinical outcomes of patients who did not undergo TTE
on day 1 in the validation cohort were not significantly
different from those who did not undergo a TTE on day
1 (Additional file 1: Table S1). In both derivation and val-
idation cohorts, the outcome status of all patients was first
ascertained from the state (New South Wales, Australia)
death registry. Surviving patients were contacted by tele-
phone for outcomes with 100% complete follow-up. This
study was approved by the institutional Human Research
Ethics Committee.
Echocardiography
A comprehensive TTE was performed with patients in
the left lateral decubitus position (Vivid5, GE Medical
Systems, Milwaukee, Wisconsin). Images were acquired
from standard echocardiographic views in accordance
with the American Society of Echocardiography recom-
mendations [21]. All images were stored digitally and
analyzed offline using commercially available software
(GE EchoPac 3.1.3, Milwaukee, Wisconsin). TTE ana-
lyses were performed in batches on anonymized images
with the operator (T.C) blinded to clinical details of each
study. All measurements were averaged over 3 consecu-
tive cardiac cycles.
In the derivation cohort, the RV was assessed by con-
ventional 2-dimensional parameters that included: the
ratio of RV and left ventricular (LV) end-diastolic diame-
ters at the basal level (tricuspid annulus); the ratio of
RV:LV end-diastolic areas; RV fractional area change
[(RV end-diastolic area - RV endsystolic area)/RV end-
diastolic area]; the ratio of right atrial (RA) and left atrial
(LA) end-systolic areas. All areas were derived by plan-
imetry from the apical 4-chamber view.
The pulmonary artery systolic pressure (PASP) was de-
rived as the sum of the tricuspid regurgitant gradient
obtained from continuous-wave Doppler and the right
atrial pressure as estimated from the inferior vena cava
[21]. The presence of McConnell’s sign (distinct akinesis
of the mid RV free wall with preserved apical motion), a
marker of RV strain and PE severity on echocardiography,
was recorded [22]. RV longitudinal function was measured
by determining the tricuspid annular plane systolic excur-
sion (TAPSE). TAPSE was determined by M-mode meas-
urement of the displacement of the lateral tricuspid
annulus during systole and diastole in the apical 4-
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by randomly selecting 10 cases and repeating all analyses
on three separate occasions with the operator blinded to
previous results. The variability is presented as the coeffi-
cient of variation (CV).
In the validation cohort, the RA/LA area ratio, RV-RA
pressure gradient, and the presence of RV dilatation and
dysfunction were recorded [24]. In both cohorts, RV
dilatation and/or dysfunction was defined as the pres-
ence of any of the following in accordance with pub-
lished guidelines: ratio of RV and LV end-diastolic
diameters >0.66; the ratio of RV:LV end-diastolic areas >
0.66; RV fractional area change < 0.35; TAPSE < 1.6 cm
and/or presence of McConnell’s sign [24].
Simplified PESI and CCI scores
The simplified PESI score is a validated index in the esti-
mation of 30-day mortality in patients with acute PE. It
incorporates the baseline demographics and comorbidities
and the size of the pulmonary embolus based on
hemodynamic status of the patient on admission. It is sim-
pler to use and has similar prognostic accuracy and clin-
ical utility as the original PESI score [3,25,26]. It
comprised of six variables of equal weight (1 point per
variable): age > 80 years old, history of cancer, history of
chronic cardiopulmonary disease (chronic lung disease
and/or heart failure), heart rate ≥110 beats per minute,
systolic blood pressure <100 mmHg and arterial oxy-
haemoglobin saturation level <90%. Patients with a simpli-
fied PESI score of <1 are classified as low risk and had a
30-day mortality of 1.0% compared to 10.9% mortality
amongst high risk patients (simplified PESI score ≥1) [3].
The CCI is a summation score of the burden of
comorbidities and it encompasses 17 different medical
conditions including: myocardial infarction, congestive
cardiac failure, peripheral vascular disease, cerebrovascu-
lar disease, dementia, chronic obstructive pulmonary
disease, connective tissue disease, peptic ulcer disease,
liver disease (mild vs. moderate to severe), diabetes (with
or without organ damage), hemiplegia, moderate to se-
vere renal disease, any tumor (within last 5 years),
lymphoma, leukemia, metastatic solid tumor and ac-
quired immunodeficiency syndrome [20]. It has been
validated in predicting in-hospital mortality when ap-
plied to ICD-10 data [27]. A value of 0 indicates no co-
morbidity, while higher values represent an increasing
burden of comorbid illnesses. A CCI score ≥3 is associ-
ated with high risk of mortality [28,29]. The simplified
PESI and CCI scores were both tested for their predic-
tion of long-term mortality post PE in our two cohorts.
Statistical analysis
Data are summarized as frequencies and percentages for
categorical variables. Continuous variables are presentedas mean ± standard deviation. Comparison between
groups used the unpaired t test for continuous variables
and χ2 tests or the Fisher exact test for dichotomous
variables. Kaplan-Meier survival methods were used to
determine long-term mortality. A single multivariate
Cox proportional hazards regression analysis was
performed for the entire cohort to assess for univariate
predictors of mortality. Only univariate variables with
p < 0.05 were included in the multivariate Cox propor-
tional hazards regression analysis. Linear mixed model-
ling was used to analyse the repeated data (RA/LA Area
Ratio at different pre-specified times post PE) and if sig-
nificant, t-test was performed at each pre-specified time
to assess for significant difference in RA/LA Area ratio
between long-term survivors and non-survivors. A p
value of <0.05 was used as a cut-off for statistical signifi-
cance. Statistical analysis was performed using GraphPad
Prism 5.01 (GraphPad Software, San Diego, Calif ), and
SPSS (Version 16.0, SPSS Inc., Chicago, Ill).
Results
Table 1 summarizes the baseline characteristics of the
derivation cohort of 35 patients and the validation
cohort of 123 patients. The mean extent of lung involve-
ment assessed by pulmonary scintigraphy in the deriv-
ation cohort was 31 ± 23% consistent with submassive
PE. This was supported by the absence of in-hospital
deaths during the index PE admission, with 10 (28.6%)
post discharge deaths over 4.3 ± 1.9 years of follow up
with one death attributable to heart failure. In the valid-
ation cohort of 123 patients, there were no in-hospital
deaths and 37 (30%) post discharge deaths over 3.4 ± 2.3
years of follow up with six deaths attributable to heart
failure. In both cohorts, the mean simplified PESI score
was <1.0, (0.9 ± 0.9 and 0.9 ± 1.0 for the derivation and
validation cohorts respectively), thus implying these pa-
tients were at low risk of short-term mortality. In
addition, the mean CCI score was <3.0 in both cohorts,
suggesting a relatively low burden of comorbid disease.
Thus both the derivation and validation cohorts had
similar baseline and clinical characteristics as well as ex-
tent of lung involvement.
Natural history of RA/LA area ratio after acute PE
To investigate whether the initial RA/LA area ratio, or
its recovery, predicted long-term outcome, we first
analysed the Day 1 RA/LA area ratio as well as its subse-
quent change for each patient over the 6 months follow-
up period in the derivation cohort and related this to
their long-term survival (Table 2). Long-term survivors
had both a lower initial and more stable RA/LA area ra-
tio (0.89 ± 0.26 and 0.83 ± 0.12 at day 1 and 6 months
after PE). In contrast, non-survivors demonstrated acute
RA dilation as evidenced by a RA/LA area ratio of 1.2 ±
Table 1 Baseline characteristics
Derivation cohort (n = 35) Validation cohort (n = 123) p value
Follow-up (years) 4.3 ± 1.9 3.4 ± 2.3 0.02*
Age, (years) 63 ± 18 68 ± 16 0.12
Male, no (%) 18 (51) 60 (49) 0.70
Comorbidities, no. (%)
Atrial fibrillation 8 (23) 29 (24) 1.00
Diabetes 9 (26) 25 (20) 0.49
Heart Failure 2 (9) 21 (17) 0.11
Hypercholesterolemia 13 (37) 22 (18) 0.02*
Ischaemic heart disease 7 (20) 34 (28) 0.51
Malignancy 8 (23) 18 (15) 0.13
Stroke 4 (11) 3 (2) 0.04*
Charlson’s Comorbidity Index (CCI) Score 1.5 ± 1.8 1.6 ± 1.9 0.79
Clinical Outcomes
Day 1 PASP, (mmHg) 33 ± 8 41 ± 16 0.006*
Simplified PESI score 0.9 ± 0.9 0.9 ± 1.0 0.88
Recurrent PE, no (%) 7 (20) 9 (7) 0.05
Death, no (%) 10 (29) 37 (30) 1.00
Values are presented as mean ± SD or absolute number.
PE Pulmonary embolism, PESI Pulmonary embolism severity index, *p < 0.05.
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months. However, no significant difference was present
between the RA/LA area ratio of survivors and non-
survivors when measured on day 2 after acute PE or
thereafter. The apparent recovery in RA/LA area ratio
on TTE between day 1 and 6 months was significantly
greater in non-survivors than survivors (−0.42 ± 0.24 vs.-
0.01 ± 0.12, p < 0.001, respectively).
In order to identify a simple measure of RA/LA area ra-
tio that may be of practical application, the RA/LA area
ratios of the derivation cohort were analysed by tertiles.
Kaplan-Meier survival analysis revealed a RA/LA area ra-
tio >1.03 on day 1 admission TTE was associated with sig-
nificantly worse long-term mortality (Figure 1). On thisTable 2 Right to left atrial area ratio and its recovery over tim
Overall (n = 35) Non-su
RA/LA Area Ratio D1 0.97 ± 0.32
RA/LA Area Ratio D2 0.87 ± 0.22
RA/LA Area Ratio D5 0.89 ± 0.21
RA/LA Area Ratio Wk 2 0.83 ± 0.24
RA/LA Area Ratio Wk 6 0.82 ± 0.15
RA/LA Area Ratio Wk 12 0.90 ± 0.20
RA/LA Area Ratio Wk 26 0.84 ± 0.12
Values are presented as mean ± SD.
Linear mixed model showed significant difference in serial measurements of RA/LA
D Day, Wk Week, LA Left atrium, RA Right atrium, *p < 0.05.basis, an initial (day 1) RA/LA area ratio >1.0 was further
investigated for its prognostic utility.Prognostic indicators in the combined cohort
In the derivation cohort, day 1 RA/LA area ratio >1.0
was an independent predictor of long-term mortality
with a hazard ratio of 5.8, adjusted for CCI score, simpli-
fied PESI score and the presence RV dilatation and dys-
function (Figure 2a). In the validation cohort, the day 1
RA/LA area ratio was significantly increased in non-
survivors than survivors (0.96 ± 0.22 vs. 0.84 ± 0.19,
p = 0.009, respectively). A day 1 RA/LA area ratio >1.0
independently predicted long-term death with a hazarde
rvivors (n = 10) Survivors (n = 25) p value
1.20 ± 0.37 0.89 ± 0.26 0.01*
0.96 ± 0.17 0.84 ± 0.23 0.23
0.98 ± 0.19 0.84 ± 0.21 0.16
0.88 ± 0.31 0.80 ± 0.22 0.67
0.82 ± 0.21 0.82 ± 0.13 0.99
0.94 ± 0.22 0.89 ± 0.19 0.63
0.86 ± 0.11 0.83 ± 0.12 0.77
area ratio over time between survivors and non-survivors, p = 0.041.







1st Tertile- RA/LA Ratio<0.77
2nd Tertile- RA/LA Ratio (0.78-1.03)
























1st Tertile 12 12 11 11 11 8
No. at Risk
2nd Tertile 11 11 11 11 11 8
No. at Risk
3rd Tertile 12 10 8 8 8 5
Figure 1 Kaplan-Meier survival curve of the Derivation Cohort
with RA/LA Area Ratio divided into tertiles. Kaplan-Meier survival
curve of the Derivation Cohort post-discharge following acute PE as
a function of the RA/LA area ratio obtained on Day 1 post PE
divided into tertiles. p = 0.04.
Figure 2 Kaplan-Meier survival analysis for the Derivation
Cohort. a: Kaplan-Meier survival curve of the Derivation Cohort:
post-discharge following acute PE utilising a cut-off of RA/LA area
ratio of 1.0 on Day 1 post PE adjusted for other variables in the
multivariate model. p = 0.04. b: Kaplan-Meier survival curve of the
Validation Cohort: post-discharge following acute PE utilising a
cut-off of RA/LA area ratio of 1.0 on Day 1 post PE adjusted for
other variables in the multivariate model. p = 0.04.
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PESI score, PASP and troponin T. (Figure 2b).
For the combined cohort, significant univariate predic-
tors of death are shown in Table 3. These include mea-
sures of comorbidity (such as CCI score), measures of
acute PE mortality risk (as measured by the simplified
PESI score and Troponin T), age and measures of right
heart dysfunction (including the day 1 RA/LA area ratio
on day 1 and PASP).
Multivariate Cox-regression analysis using backward se-
lection modelling identified the day 1 RA/LA area ratio
(hazard ratio [HR] 1.7 per 10% increase, 95% confidence
interval [CI] 1.2-2.4, p = 0.002), the CCI score (HR 2.2 per
1 unit increase, 95% CI 1.3-3.7, p = 0.004) and age (HR 1.1
per year increase, 95% CI 1.0-1.2, p = 0.03) as independent
predictors of mortality (Table 4). Intraobserver variability
was less than 10% for conventional echocardiographic
parameters, which is consistent with reported literature
[30,31]. In particular, the coefficient of variation (CV) for
RA:LA end-systolic area was 5%.
Discussion
The ability of echocardiography to predict long-term
mortality after a submassive PE is not clear. Echocardi-
ography is recommended during the acute managementof PE to assess RV dysfunction so as to further stratify
non-hemodynamically compromised patients into inter-
mediate or low-risk prognostic categories [6]. In the
current study, we report for the first time that the day 1
RA/LA area ratio on echocardiography in patients with
acute submassive PE predicted long-term mortality in
both the derivation and validation cohorts. A day 1 RA/
LA area ratio >1.0 on presentation conferred at least a
three-fold increase in long-term mortality. This was
independent of the expected predictive value of the
Charlson Comorbidity Index and simplified PESI Scores.
Table 3 Univariate predictors of long-term mortality for the combined cohort (n = 158)
Hazard ratio 95% CI p value
Baseline Characteristics
Age, per year increase 1.06 1.03-1.10 <0.001*
CCI score age unadjusted, per 1 unit increase 1.8 1.4-2.2 <0.001*
Simplified PESI score, per 1 unit increase 2.1 1.5-3.2 <0.001*
Troponin T, per 0.01 increase 1.1 1.03-1.25 0.008*
RV parameters on Echocardiography
RA/LA Area Ratio (D1), per 10% increase 1.3 1.1-1.5 0.001*
RV dilation and dysfunction 0.6 0.3-1.2 0.16
PASP, per mmHg increase 1.04 1.01-1.07 0.007*
CCI Charlson Comorbidity Index, D1 Day 1, LA Left atrium, PASP Pulmonary artery systolic pressure, PESI Pulmonary embolus severity index, RA Right atrium, RV
Right ventricle. * p < 0.05.
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afterload. The RA and RV are thin walled and low pres-
sure chambers, unlike the LV, and have limited capacity
to compensate to the elevated RV wall tension. This re-
sults in RV dilation and dysfunction and worsening tri-
cuspid regurgitation.
Previous studies have shown the presence of RV dys-
function post PE, in particular an increased RV/LV ratio,
by both computed tomography pulmonary angiography
(CTPA) and TTE, correlated with clinical outcomes and
short-term mortality [32-37]. However in other studies,
no clear association could be demonstrated [38,39]. This
discrepancy may be due to absence of an uniformly ac-
cepted standard for measuring the ventricular volumes
on CT and the lack of electrocardiographic gating of the
CTPA [40].
The RA/LA area ratio reflects the integration of mul-
tiple haemodynamic parameters including diastolic and
systolic function of the RV, and filling volumes and pres-
sures of the LA and LV. Amongst the general population
without a history of pulmonary embolism, the RA/LA
area ratio has been reported to be 0.81 ± 0.15 [41]. A
raised RA/LA area ratio has previously been shown by
our group to correlate with the extent of pulmonary
artery occlusion after PE [18]. In acute PE, the sudden
increase in RV afterload can lead to RV and RA dilation.
This additionally impairs left- atrial and ventricular dia-
stolic filling due to deviation of the inter-atrial and inter-
ventricular septae leftwards. These changes have beenTable 4 Multivariate backward selection model for combined
Hazar
RA/LA Area Ratio (D1), per 10% increase 1
CCI score age unadjusted, per 1 unit increase 2
Age, per year increase 1
Simplified PESI score, per 1 unit increase 2
CCI Charlson Comorbidity Index, D1 Day 1, LA Left atrium, PASP Pulmonary artery sy
Right ventricle. * p < 0.05.observed on CT scans in patients with massive PE
[42,43]. A relative increase in RA and RV volumes
coupled with decrease in LA and LV volumes leads to an
increased RA/LA area ratio. Our results indicate that
these changes are also evident in submassive PE without
hemodynamic instability and are dynamic.
While it may be expected that RA/LA area ratio may
relate to early outcome, the association with long-term
outcome as demonstrated in the present study is novel.
A particularly important finding of our study is that
there is an acute recovery of the RA/LA area ratio and
that this recovery does not predict a favourable long-
term outcome. Therefore, TTE performed on or after
day 2 of PE presentation in earlier studies are likely to
underestimate the prognostic utility of the RA/LA area
ratio. Pathophysiologically, our study indicates that it is
the initial cardiac response to the thromboembolic insult
and not the subsequent recovery that predicts long-term
outcome. That the RA/LA area ratio is highly dynamic
and responds acutely to volume and pressure change has
been shown previously after percutaenous atrial septal
defect closure. Within 24 hours of closure, Kelly et al.
observed significant and immediate decrease in the RA/
LA area ratio compared with baseline TTE, despite an
extended period prior with significant right sided volume
overload [41]. This is due to the immediate volume and
pressure unloading of the right heart, with complete
normalization of the RA/LA area ratio at early follow-
up. We postulate a similar mechanism occurs in patientscohort (n = 158)





stolic pressure, PESI Pulmonary embolus severity index, RA Right atrium, RV
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more acutely and therefore making these changes more re-
versible. Following the commencement of anticoagulation
therapy and the resulting reduction in thromboembolic
burden in the pulmonary vasculature, there is an immedi-
ate volume and pressure unloading of the right heart with
improvement in the RA/LA area ratio within 24 hours.
Presumably, these patients with elevated RA/LA area ratio
on Day 1 indicate a reduced cardiac-pulmonary capacity
to cope with increased RV afterload, even if there is nor-
malisation of the RA/LA area ratio over the first week of
treatment independent of the initial PE size as calculated
by the simplified PESI score.
The RA/LA area ratio is simple to measure and a cut-
off of day 1 RA/LA area ratio >1.0 may be a practical
guide for physicians to identify patients who are at
increased risk of death in the long-term following
submassive PE. In particular, we have identified 17 of the
37 (46%) deaths in the validation cohort were cardiovas-
cular or recurrent pulmonary embolus deaths which
may have been preventable. These patients may benefit
from long term follow-up and closer surveillance [6,7] to
ensure appropriate anticoagulation therapy is provided
and that there is normalisation of the RA/LA area ratio
and RV function with normalisation of pulmonary
haemodynamics.
The CCI is a summation score of the burden of
Comorbidities [20] shown to be very useful in prognosti-
cating the outcome of patients suffering from diseases
including heart failure [44], endocarditis [45] and cancer
[46]. In our current study, we confirmed the CCI is an
independent predictor of long-term death following
submassive PE. Among the included comorbidities in
the CCI are cardiovascular diseases, chronic pulmonary
diseases and malignancies. These comorbid illnesses
have previously been found to be present in patients
presenting with venous thromboembolism [47] and were
predictors of long-term functional impairment[48] and
survival [14]. We have shown for the first time that a
simple and easily obtained echocardiographic parameter,
the RA/LA area ratio, is an independent predictor of
long-term survival following acute PE.Limitations
This study is limited by its sample size. This may explain
why cardiac troponin-T and BNP levels, which were
raised amongst the non-survivors, were not independent
predictors of long-term mortality following multivariate
analysis in our combined cohort. We have recently
demonstrated a concentration-dependent relationship
between cardiac troponin-T elevation following acute PE
and long-term mortality [13] and it will be important to
extend the present study into larger patient cohorts todirectly compare RA/LA area ratio and biochemical pa-
rameters in predicting long-term outcome.
Conclusion
In summary, patients suffering from pulmonary embolus
have significantly increased long-term mortality. The early
echocardiographic RA/LA area ratio is a simple, robust
and easily reproducible measurement, which independ-
ently predicted long-term mortality amongst PE patients.
A day 1 RA/LA area ratio >1.0 is independently associated
with a three-fold increase in long-term mortality and this
novel echocardiographic parameter may aid the long-term
risk stratification following acute submassive PE.
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